Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Columbia University
M.D. Anderson Cancer Center
Fondazione Italiana Linfomi - ETS
Institute of Hematology & Blood Diseases Hospital, China
Columbia University
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
Mayo Clinic
Columbia University
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
University of Alabama at Birmingham
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Centre for Human Drug Research, Netherlands
Beijing GoBroad Hospital
Case Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Beijing GoBroad Hospital
Thomas Jefferson University
City of Hope Medical Center
Fox Chase Cancer Center
City of Hope Medical Center
Yale University
Lund University Hospital
Ohio State University Comprehensive Cancer Center
University College, London
Centre Hospitalier Universitaire de Besancon
Northwestern University
Assistance Publique - Hôpitaux de Paris
Dana-Farber Cancer Institute